Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ARC Document Solutions | ARC | Sep 3, 2024 | 3.35 | +0.30 |
ARCA biopharma | ABIO | Sep 3, 2024 | 2.40 | 0.00 |
Arcadia Biosciences | RKDA | Sep 3, 2024 | 2.71 | -12.79 |
Arcadium Lithium | ALTM | Sep 3, 2024 | 2.45 | -9.59 |
ArcBest | ARCB | Sep 3, 2024 | 105.30 | -0.94 |
Arcellx | ACLX | Sep 3, 2024 | 66.12 | -3.81 |
Arcelor Mittal ADR | MT | Sep 3, 2024 | 22.10 | -6.44 |
Arch Capital F Pref | ACGLO | Sep 3, 2024 | 23.34 | +0.60 |
Arch Capital G | ACGLN | Sep 3, 2024 | 20.22 | +0.15 |
Arch Capital Group | ACGL | Sep 3, 2024 | 113.25 | +0.14 |
Arch Resources A | ARCH | Sep 3, 2024 | 130.15 | -4.60 |
Archer Aviation A | ACHR | Sep 3, 2024 | 3.38 | -0.59 |
Archer Daniels Midland | ADM | Sep 3, 2024 | 60.62 | -0.61 |
Archrock | AROC | Sep 3, 2024 | 19.05 | -5.83 |
Arcos Dorados | ARCO | Sep 3, 2024 | 8.61 | -2.16 |
Arcosa | ACA | Sep 3, 2024 | 86.23 | -5.75 |
Arcturus Therapeutics | ARCT | Sep 3, 2024 | 19.39 | -8.10 |
Arcus Biosciences | RCUS | Sep 3, 2024 | 16.57 | -3.21 |
Arcutis Biotherapeutics | ARQT | Sep 3, 2024 | 10.50 | -3.49 |
Ardagh Metal Packaging | AMBP | Sep 3, 2024 | 3.53 | -1.40 |
Ardelyx | ARDX | Sep 3, 2024 | 5.63 | -8.90 |
Ardent Health Partners | ARDT | Sep 3, 2024 | 19.30 | 0.00 |
Ardmore Shipping | ASC | Sep 3, 2024 | 17.61 | -6.73 |
Ares Acquisition II | AACT | Sep 3, 2024 | 10.78 | +0.14 |
Ares Capital | ARCC | Sep 3, 2024 | 21.00 | -0.38 |
Ares Commercial Real Estate | ACRE | Sep 3, 2024 | 7.06 | 0.00 |
Ares Dynamic Credit Allocation Fund | ARDC | Sep 3, 2024 | 15.42 | +0.33 |
Ares Management A | ARES | Sep 3, 2024 | 142.02 | -2.99 |
Argan | AGX | Sep 3, 2024 | 72.58 | -8.49 |
argenx ADR | ARGX | Sep 3, 2024 | 514.23 | -0.60 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.